Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 3/20 | 0.64 |
| ▸ | POLG | P54098 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.40 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.40 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.40 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.40 |
| ▸ | DCK | P27707 | 11/20 | 0.36 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.32 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12125352 | 0.80 | ALB (0.48) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL12202574 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL3722124 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine, (+/-)- SCHEMBL122131 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL5427218 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL267686 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL39708 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL6903677 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL22413085 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F | |
| Emtricitabine SCHEMBL6362885 | 0.78 | ALB (1.00) | ALBPOLGLMNAPDE3ACACNA1F |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050192299-A1 | Method of treating or preventing hepatitis B virus | CHENG YUNG-CHI (US) | 2005-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192299-A1 | Method of treating or preventing hepatitis B virus | CDA, DCTD, TTPA | ALB 720/4885POLG 807/4885LMNA 882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.